| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Achieving and maintaining quality in the laboratory
|
HERTZBERG, M. S.
|
|
2006
|
12 |
s3 |
p. 61-67
|
artikel
|
| 2 |
Cellular and genetic therapies for haemophilia
|
LILLICRAP, D.
|
|
2006
|
12 |
s3 |
p. 36-41
|
artikel
|
| 3 |
Congenital platelet disorders: overview of their mechanisms, diagnostic evaluation and treatment
|
HAYWARD, C. P. M.
|
|
2006
|
12 |
s3 |
p. 128-136
|
artikel
|
| 4 |
Current understanding of von Willebrand's disease in women – some answers, more questions
|
KOUIDES, P. A.
|
|
2006
|
12 |
s3 |
p. 143-151
|
artikel
|
| 5 |
Ethical issues in haemophilia
|
DIMICHELE, D.
|
|
2006
|
12 |
s3 |
p. 30-35
|
artikel
|
| 6 |
Genetic diagnosis of haemophilia and other inherited bleeding disorders
|
PEYVANDI, F.
|
|
2006
|
12 |
s3 |
p. 82-89
|
artikel
|
| 7 |
Haemophilia and ageing
|
STREET, A.
|
|
2006
|
12 |
s3 |
p. 8-12
|
artikel
|
| 8 |
HIV and HCV coinfected haemophilia patients: what are the best options of orthopaedic treatment?
|
RODRIGUEZ-MERCHAN, E. C.
|
|
2006
|
12 |
s3 |
p. 90-101
|
artikel
|
| 9 |
Laboratory issues in bleeding disorders
|
LILLICRAP, D.
|
|
2006
|
12 |
s3 |
p. 68-75
|
artikel
|
| 10 |
New approaches for measuring coagulation
|
BARROWCLIFFE, T. W.
|
|
2006
|
12 |
s3 |
p. 76-81
|
artikel
|
| 11 |
Pathogenesis of haemophilic arthropathy
|
ROOSENDAAL, G.
|
|
2006
|
12 |
s3 |
p. 117-121
|
artikel
|
| 12 |
Physiotherapy following elective orthopaedic procedures
|
DE KLEIJN, P.
|
|
2006
|
12 |
s3 |
p. 108-112
|
artikel
|
| 13 |
Prevention and treatment of musculoskeletal disease in the haemophilia population: role of prophylaxis and synovectomy
|
VAN DEN BERG, H. M.
|
|
2006
|
12 |
s3 |
p. 159-168
|
artikel
|
| 14 |
Quality of life assessment in clinical practice in haemophilia treatment
|
GRINGERI, A.
|
|
2006
|
12 |
s3 |
p. 22-29
|
artikel
|
| 15 |
Rare bleeding disorders
|
PEYVANDI, F.
|
|
2006
|
12 |
s3 |
p. 137-142
|
artikel
|
| 16 |
Recent developments in clinimetric instruments
|
BEETON, K.
|
|
2006
|
12 |
s3 |
p. 102-107
|
artikel
|
| 17 |
Strategies towards a longer acting factor VIII
|
SAENKO, E. L.
|
|
2006
|
12 |
s3 |
p. 42-51
|
artikel
|
| 18 |
The natural evolution of haemophilia care: developing and sustaining comprehensive care globally
|
EVATT, B. L.
|
|
2006
|
12 |
s3 |
p. 13-21
|
artikel
|
| 19 |
The pharmacokinetics of coagulation factors
|
LEE, M.
|
|
2006
|
12 |
s3 |
p. 1-7
|
artikel
|
| 20 |
Tissue engineering in musculoskeletal problems related to haemophilia
|
CAVIGLIA, H.
|
|
2006
|
12 |
s3 |
p. 122-127
|
artikel
|
| 21 |
Total joint replacement in patients with inhibitors
|
SOLIMENO, L. P.
|
|
2006
|
12 |
s3 |
p. 113-116
|
artikel
|
| 22 |
Treatment for all: a vision for the future
|
SKINNER, M. W.
|
|
2006
|
12 |
s3 |
p. 169-173
|
artikel
|
| 23 |
Von Willebrand's disease: clinical management
|
FEDERICI, A. B.
|
|
2006
|
12 |
s3 |
p. 152-158
|
artikel
|
| 24 |
Why do inhibitors develop? Principles of and factors influencing the risk for inhibitor development in haemophilia
|
ASTERMARK, J.
|
|
2006
|
12 |
s3 |
p. 52-60
|
artikel
|
Tijdschrift beschrijving